TY - JOUR
T1 - Programmable Molecular Scissors
T2 - Applications of a New Tool for Genome Editing in Biotech
AU - Saha, Subbroto Kumar
AU - Saikot, Forhad Karim
AU - Rahman, Md Shahedur
AU - Jamal, Mohammad Abu Hena Mostofa
AU - Rahman, S. M.Khaledur
AU - Islam, S. M.Riazul
AU - Kim, Ki Hyun
N1 - Funding Information:
This work was supported by the KU-Research Professor Program of Konkuk University . This study was partially supported by a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning , South Korea (grant 2016R1E1A1A01940995 ).
Publisher Copyright:
© 2018 The Author(s)
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Targeted genome editing is an advanced technique that enables precise modification of the nucleic acid sequences in a genome. Genome editing is typically performed using tools, such as molecular scissors, to cut a defined location in a specific gene. Genome editing has impacted various fields of biotechnology, such as agriculture; biopharmaceutical production; studies on the structure, regulation, and function of the genome; and the creation of transgenic organisms and cell lines. Although genome editing is used frequently, it has several limitations. Here, we provide an overview of well-studied genome-editing nucleases, including single-stranded oligodeoxynucleotides (ssODNs), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and CRISPR-Cas9 RNA-guided nucleases (CRISPR-Cas9). To this end, we describe the progress toward editable nuclease-based therapies and discuss the minimization of off-target mutagenesis. Future prospects of this challenging scientific field are also discussed.
AB - Targeted genome editing is an advanced technique that enables precise modification of the nucleic acid sequences in a genome. Genome editing is typically performed using tools, such as molecular scissors, to cut a defined location in a specific gene. Genome editing has impacted various fields of biotechnology, such as agriculture; biopharmaceutical production; studies on the structure, regulation, and function of the genome; and the creation of transgenic organisms and cell lines. Although genome editing is used frequently, it has several limitations. Here, we provide an overview of well-studied genome-editing nucleases, including single-stranded oligodeoxynucleotides (ssODNs), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and CRISPR-Cas9 RNA-guided nucleases (CRISPR-Cas9). To this end, we describe the progress toward editable nuclease-based therapies and discuss the minimization of off-target mutagenesis. Future prospects of this challenging scientific field are also discussed.
KW - CRISPR-Cas9
KW - DSB
KW - genome editing
KW - HDR
KW - NHEJ
KW - nucleases
KW - off-target mutagenesis
KW - ssODNs
KW - TALENs
KW - ZFNs
UR - http://www.scopus.com/inward/record.url?scp=85059566993&partnerID=8YFLogxK
U2 - 10.1016/j.omtn.2018.11.016
DO - 10.1016/j.omtn.2018.11.016
M3 - Review article
AN - SCOPUS:85059566993
VL - 14
SP - 212
EP - 238
JO - Molecular Therapy Nucleic Acids
JF - Molecular Therapy Nucleic Acids
SN - 2162-2531
ER -